Contraception in the setting of gynecologic and breast dysplasia

Isabel Beshar & Paul D. Blumenthal et al. · 2025-10-28

Purpose of review

There is limited data on contraceptive options in the setting of gynecologic and breast dysplasia. Despite this, many patients who report a history of these precancers retain their reproductive organs and seek contraception to avoid pregnancy. These patients require evidence-based counseling to guide their contraceptive choices, particularly in the setting of hormonally driven pathology.

Recent findings

In this review article, we outline known data on contraceptive options for patients with borderline ovarian tumors, endometrial hyperplasia, cervical/vulvar dysplasia, and atypical lobular and ductal hyperplasia. We also identify gaps in knowledge and opportunities for further research.

Summary

Patients with gynecologic and breast dysplasia benefit from comprehensive contraception counseling. More research is needed on contraceptive options for patients with dysplasia.

Authors
Isabel Beshar, Lauren J. Tostrud, Talayeh Ghezelayagh, Paul D. Blumenthal
Funding
CTSA K12 Program at StanfordCTSA K12 Program at Stanford

NCATS NIH HHS

K12 TR004930

National Center for Advancing Translational Sciences of the National Institutes of

K12TR004930